DROSHA-Dependent miRNA and AIM2 Inflammasome Activation in Idiopathic Pulmonary Fibrosis

Soo Jung Cho1,2, Mihye Lee3, Heather W Stout-Delgado1,2

  • 1Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY 10011, USA.

Insights

Idiopathic pulmonary fibrosis involves chronic lung inflammation. This review explores how DROSHA, microRNA, and the AIM2 inflammasome pathway contribute to IPF development and progression.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Immunology

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease.
  • Chronic lung inflammation is a key factor in IPF pathogenesis.
  • MicroRNAs (miRNAs) regulate inflammatory responses.

Purpose of the Study:

  • To review recent advances in understanding the DROSHA-miRNA-AIM2 inflammasome axis.
  • To elucidate the role of this axis in IPF pathogenesis.

Main Methods:

  • This is a review article, synthesizing existing research.
  • Focuses on the molecular mechanisms of DROSHA, miRNAs, and the AIM2 inflammasome.
  • Examines their interplay in the context of lung inflammation and fibrosis.

Main Results:

  • DROSHA is crucial for miRNA biogenesis, influencing gene expression.
  • The AIM2 inflammasome senses DNA and drives inflammatory responses, including IL-1β and IL-18 secretion.
  • Inflammasome activation is implicated in IPF-related lung inflammation and fibrogenesis.

Conclusions:

  • The DROSHA-miRNA-AIM2 inflammasome axis represents a significant pathway in IPF pathogenesis.
  • Understanding this axis offers potential therapeutic targets for IPF.
  • Further research into this pathway is warranted for IPF treatment strategies.